
![]() |
![]() |
![]() |
![]() |
![]() |
Terms & Properties |
Concept Unique Identifier (CUI): C0023281
NCI Thesaurus Code: C34767 (see NCI Thesaurus info)
Semantic Type: Disease or Syndrome
NCIt Definition: A parasitic infection caused by protozoa of the genus Leishmania. It is transmitted to humans via the bite of sandflies. There are three main forms of the disease: cutaneous, mucocutaneous, and visceral leishmaniasis. Cutaneous leishmaniasis causes skin ulcers; mucocutaneous leishmaniasis causes destructive lesions of the mucous membranes of the nose, mouth, and throat; visceral leishmaniasis is the most severe form of the disease and is manifested with anemia, weight loss, hepatomegaly and splenomegaly.
GARD Definition: Leishmaniasis is a parasitic disease spread by the bite of infected sand flies. There are several different forms of leishmaniasis. The most common are cutaneous and visceral. The cutaneous type causes skin sores. The visceral type affects internal organs such as the spleen, liver and bone marrow. People with this form usually have fever, weight loss, and an enlarged spleen and liver. Visceral disease can be deadly without proper treatment. Leishmaniasis is found in parts of the Middle East, Central America, South American, Asia, Africa, and southern Europe. Most of these countries are in the tropics and subtropics. It is possible but very unlikely to get this disease in the United States. - this information is from GARD/ORDR/NCATS.
MEDLINEPLUS Definition:
Leishmaniasis is a parasitic disease spread by the bite of infected sand flies. There are several different forms of leishmaniasis. The most common are cutaneous and visceral. The cutaneous type causes skin sores. The visceral type affects internal organs such as the spleen, liver, and bone marrow. People with this form usually have fever, weight loss, and an enlarged spleen and liver.
Leishmaniasis is found in parts of about 88 countries. Most of these countries are in the tropics and subtropics. It is possible but very unlikely that you would get this disease in the United States. But you should be aware of it if you are traveling to the Middle East or parts of Central America, South America, Asia, Africa or southern Europe.
Treatment is with medicines that contain antimony, a type of metal, or with strong antibiotics. The best way to prevent the disease is to protect yourself from sand fly bites:
Centers for Disease Control and Prevention
NICHD Definition: A protozoan infection that is caused by members of the genus Leishmania, which is transmitted to humans via the bite of sandflies. There are three main forms of the disease: cutaneous, mucocutaneous, and visceral.
CSP Definition: disease caused by any of a number of species of protozoa in the genus Leishmania; there are four major clinical types of this infection: cutaneous (Old and New World), diffuse cutaneous, mucocutaneous, and visceral; visceral is characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin; cutaneous is characterized by development of single or multiple localized lesions on exposed areas of skin that typically ulcerate.
MSH Definition: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
Synonyms & Abbreviations: (see Synonym Details)
Leishmania infections |
Leishmaniases |
Leishmaniasis (disorder) |
Leishmaniasis [Disease/Finding] |
Leishmaniasis NOS |
Leishmaniasis, unspecified |
leishmaniasis |
Leishmaniosis |
External Source Codes:
NCI Thesaurus Code | C34767 (see NCI Thesaurus info) |
Name | Value | Source |
---|---|---|
ACTIVE | 1 | SNOMEDCT_US |
AN | general or unspecified; prefer specifics; coordinate with NEGLECTED DISEASES if pertinent; LEISHMANIASIS, AMERICAN see LEISHMANIASIS, CUTANEOUS is also available; tegumentary leishmaniasis = LEISHMANIASIS, CUTANEOUS | MSH |
AQL | BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI | MSH |
CASE_SIGNIFICANCE_ID | 900000000000448009 | SNOMEDCT_US |
CHARACTERISTIC_TYPE_ID | 900000000000011006 | SNOMEDCT_US |
Contributing_Source | NICHD | NCI |
CTV3ID | A85.. | SNOMEDCT_US |
DATE_CREATED | 02/17/2004 | MEDLINEPLUS |
DC | 1 | MSH |
DEFINITION_STATUS_ID | 900000000000073002 | SNOMEDCT_US |
DID | 2214-5416 | CSP |
DX | 19660101 | MSH |
EFFECTIVE_TIME | 20020131 | SNOMEDCT_US |
HAS_GARD_PAGE | true | GARD |
IAN | DEFAULT | ICD10 |
IS_RARE | true | GARD |
IS_SPANISH | false | GARD |
MDA | 19990101 | MSH |
MESH_DEFINITION | A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). | NDFRT |
MESH_DUI | D007896 | NDFRT |
MESH_NAME | Leishmaniasis | NDFRT |
MESH_UI | M0012333 | NDFRT |
MMR | 20121204 | MSH |
MN | C03.752.300.500 | MSH |
MN | C03.858.560 | MSH |
MN | C17.800.838.775.560 | MSH |
MODIFIER_ID | 900000000000451002 | SNOMEDCT_US |
MP_HEALTH_TOPIC_URL | https://www.nlm.nih.gov/medlineplus/leishmaniasis.html | MEDLINEPLUS |
MP_OTHER_LANGUAGE_URL | Arabic https://www.nlm.nih.gov/medlineplus/languages/leishmaniasis.html#Arabic | MEDLINEPLUS |
MP_OTHER_LANGUAGE_URL | Spanish https://www.nlm.nih.gov/medlineplus/spanish/leishmaniasis.html | MEDLINEPLUS |
MP_PRIMARY_INSTITUTE_URL | National Institute of Allergy and Infectious Diseases http://www.niaid.nih.gov/ | MEDLINEPLUS |
NDFRT_KIND | DISEASE_KIND | NDFRT |
NICHD_Hierarchy_Term | Leishmaniasis | NCI |
NUI | N0000001804 | NDFRT |
ORDER_NO | 01040 | ICD10CM |
ORDER_NO | 01044 | ICD10CM |
PRIMARY_PATH | 10024198$10057168$10037072$10021881$Leishmaniasis$Leishmania infections$Protozoal infectious disorders$Infections and infestations | MDR |
PRIMARY_SOC | 10021881 | MDR |
PT_IN_VERSION | 10.0 | MDR |
PT_IN_VERSION | 10.1 | MDR |
PT_IN_VERSION | 11.0 | MDR |
PT_IN_VERSION | 11.1 | MDR |
PT_IN_VERSION | 12.0 | MDR |
PT_IN_VERSION | 12.1 | MDR |
PT_IN_VERSION | 13.0 | MDR |
PT_IN_VERSION | 13.1 | MDR |
PT_IN_VERSION | 14.0 | MDR |
PT_IN_VERSION | 14.1 | MDR |
PT_IN_VERSION | 15.0 | MDR |
PT_IN_VERSION | 15.1 | MDR |
PT_IN_VERSION | 16.0 | MDR |
PT_IN_VERSION | 16.1 | MDR |
PT_IN_VERSION | 17.0 | MDR |
PT_IN_VERSION | 17.1 | MDR |
PT_IN_VERSION | 18.0 | MDR |
PT_IN_VERSION | 18.1 | MDR |
PT_IN_VERSION | 19.0 | MDR |
PT_IN_VERSION | 19.1 | MDR |
PT_IN_VERSION | 20.0 | MDR |
PT_IN_VERSION | 20.1 | MDR |
PT_IN_VERSION | 8.0 | MDR |
PT_IN_VERSION | 8.1 | MDR |
PT_IN_VERSION | 9.0 | MDR |
PT_IN_VERSION | 9.1 | MDR |
RARE_DISEASE_URL | http://rarediseases.info.nih.gov/gard/6881/leishmaniasis/resources/1 | GARD |
RXAUI | 3188573 | RXNORM |
RXAUI | 3188576 | RXNORM |
RXCUI | 1026755 | RXNORM |
SNOMED_CID | 80612004 | NDFRT |
SUBSET_MEMBER | 447562003~CORRELATIONID~447561005 | SNOMEDCT_US |
SUBSET_MEMBER | 447562003~MAPADVICE~ALWAYS B55.9 | SNOMEDCT_US |
SUBSET_MEMBER | 447562003~MAPCATEGORYID~447637006 | SNOMEDCT_US |
SUBSET_MEMBER | 447562003~MAPGROUP~1 | SNOMEDCT_US |
SUBSET_MEMBER | 447562003~MAPPRIORITY~1 | SNOMEDCT_US |
SUBSET_MEMBER | 447562003~MAPRULE~TRUE | SNOMEDCT_US |
SUBSET_MEMBER | 447562003~MAPTARGET~B55.9 | SNOMEDCT_US |
SUBSET_MEMBER | 6011000124106~CORRELATIONID~447561005 | SNOMEDCT_US |
SUBSET_MEMBER | 6011000124106~MAPADVICE~ALWAYS B55.9 | DESCENDANTS NOT EXHAUSTIVELY MAPPED | SNOMEDCT_US |
SUBSET_MEMBER | 6011000124106~MAPADVICE~IF AGE AT ONSET OF CLINICAL FINDING BEFORE 1.0 YEAR CHOOSE B55.0 | DESCENDANTS NOT EXHAUSTIVELY MAPPED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT | SNOMEDCT_US |
SUBSET_MEMBER | 6011000124106~MAPCATEGORYID~447637006 | SNOMEDCT_US |
SUBSET_MEMBER | 6011000124106~MAPCATEGORYID~447639009 | SNOMEDCT_US |
SUBSET_MEMBER | 6011000124106~MAPGROUP~1 | SNOMEDCT_US |
SUBSET_MEMBER | 6011000124106~MAPPRIORITY~1 | SNOMEDCT_US |
SUBSET_MEMBER | 6011000124106~MAPPRIORITY~2 | SNOMEDCT_US |
SUBSET_MEMBER | 6011000124106~MAPRULE~IFA 445518008 | Age at onset of clinical finding (observable entity) | < 1.0 year | SNOMEDCT_US |
SUBSET_MEMBER | 6011000124106~MAPRULE~OTHERWISE TRUE | SNOMEDCT_US |
SUBSET_MEMBER | 6011000124106~MAPTARGET~B55.0 | SNOMEDCT_US |
SUBSET_MEMBER | 6011000124106~MAPTARGET~B55.9 | SNOMEDCT_US |
SUBSET_MEMBER | 900000000000497000~MAPTARGET~A85.. | SNOMEDCT_US |
SUBSET_MEMBER | 900000000000508004~ACCEPTABILITYID~900000000000548007 | SNOMEDCT_US |
SUBSET_MEMBER | 900000000000508004~ACCEPTABILITYID~900000000000549004 | SNOMEDCT_US |
SUBSET_MEMBER | 900000000000509007~ACCEPTABILITYID~900000000000548007 | SNOMEDCT_US |
SUBSET_MEMBER | 900000000000509007~ACCEPTABILITYID~900000000000549004 | SNOMEDCT_US |
TERMUI | T023564 | MSH |
TH | ORD (2010) | MSH |
TH | POPLINE (1994) | MSH |
TYPE_ID | 900000000000003001 | SNOMEDCT_US |
TYPE_ID | 900000000000013009 | SNOMEDCT_US |
Additional Concept Data: (none)
URL to Bookmark: https://ncim-stage.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI Metathesaurus&code=C0023281